> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Issues Section 506J Notification Obligation Table
- URL: https://www.fdaweb.com/fda-issues-section-506j-notification-obligation-table/
- Published: 2021-03-09T12:00:00.000Z
- Updated: 2026-09-14T16:50:03.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5148834

FDA has issued a table to be used with its 11/2020 immediately-in-effect guidance [*Permanent Discontinuance or Interruption in Manufacturing of a Device under Section 506J of the Federal Food, Drug, and Cosmetic Act During the Covid-19 Public Health Emergency*](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/notifying-cdrh-permanent-discontinuance-or-interruption-manufacturing-device-under-section-506j-fdc?ref=fdaweb.com). The [table](https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/medical-device-types-help-determine-section-506j-notification-obligations?ref=fdaweb.com) contains the agency’s recommendations based on its current understanding of the device types and corresponding product codes that manufacturers should consider to determine whether they are required to notify the agency under section 506J during the Covid-19 pandemic. FDA says it will update the table as the pandemic evolves.

“This table of device types and corresponding product codes identifies devices that FDA believes are critical to the public health during the Covid-19 pandemic under section 506J(a)(1) of the Federal Food, Drug, and Cosmetic Act (FFDCA),” FDA says. “However, FDA may make additional device type determinations under section 506J(a)(2) of the FFDCA and update this table concerning device type recommendations under section 506J(a)(1) of the FFDCA as this public health emergency evolves and if FDA learns new information.”